Cargando…

Surgical Strategies for Recurrent Hepatocellular Carcinoma after Resection: A Review of Current Evidence

SIMPLE SUMMARY: Among primary liver cancers, hepatocellular carcinoma (HCC) is the most common. Surgical resection and liver transplantation both represent potentially curative treatments not only in the case of the first occurrence, but also in those cases of disease recurrence if a proper selectio...

Descripción completa

Detalles Bibliográficos
Autores principales: Milana, Flavio, Polidoro, Michela Anna, Famularo, Simone, Lleo, Ana, Boldorini, Renzo, Donadon, Matteo, Torzilli, Guido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856445/
https://www.ncbi.nlm.nih.gov/pubmed/36672457
http://dx.doi.org/10.3390/cancers15020508
_version_ 1784873631371755520
author Milana, Flavio
Polidoro, Michela Anna
Famularo, Simone
Lleo, Ana
Boldorini, Renzo
Donadon, Matteo
Torzilli, Guido
author_facet Milana, Flavio
Polidoro, Michela Anna
Famularo, Simone
Lleo, Ana
Boldorini, Renzo
Donadon, Matteo
Torzilli, Guido
author_sort Milana, Flavio
collection PubMed
description SIMPLE SUMMARY: Among primary liver cancers, hepatocellular carcinoma (HCC) is the most common. Surgical resection and liver transplantation both represent potentially curative treatments not only in the case of the first occurrence, but also in those cases of disease recurrence if a proper selection of patients is performed ahead. Incidentally, the type and the time of relapse carry important weight on patient prognosis and overall survival. For these cases, proper management has still not been exactly defined. If precise indications for HCC first occurrence are quite clear, very few clear indications have been reported in those cases of relapse. The authors, after an extensive review of the published literature, aimed to summarize the modalities and the histopathological patterns of HCC recurrence, their prognostic value, and the main surgical strategies to deal with HCC relapse. At this point, either for redo hepatectomy or salvage liver transplantation, the pros and the cons have been detailed with the aim of characterizing the most suitable patients for receiving one or another. Some studies where such treatments were compared have been reported as well. ABSTRACT: Hepatocellular carcinoma (HCC) is the most common primary liver cancer, and both liver resection and liver transplantation are considered potentially curative options. However, high recurrence rates affect the prognosis depending both on the primary HCC pathology characteristics or on the type and time of the relapse. While great attention has been usually posted on treatment algorithms for the first HCC, treatment algorithms for recurrent HCC (rHCC) are lacking. In these cases, surgery still represents a curative option with both redo hepatectomy and/or salvage liver transplantation, which are considered valid treatments in selected patients. In the current era of personalised medicine with promises of new systemic-targeted immuno-chemotherapies, we wished to perform a narrative review of the literature on the role of surgical strategies for rHCC.
format Online
Article
Text
id pubmed-9856445
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98564452023-01-21 Surgical Strategies for Recurrent Hepatocellular Carcinoma after Resection: A Review of Current Evidence Milana, Flavio Polidoro, Michela Anna Famularo, Simone Lleo, Ana Boldorini, Renzo Donadon, Matteo Torzilli, Guido Cancers (Basel) Review SIMPLE SUMMARY: Among primary liver cancers, hepatocellular carcinoma (HCC) is the most common. Surgical resection and liver transplantation both represent potentially curative treatments not only in the case of the first occurrence, but also in those cases of disease recurrence if a proper selection of patients is performed ahead. Incidentally, the type and the time of relapse carry important weight on patient prognosis and overall survival. For these cases, proper management has still not been exactly defined. If precise indications for HCC first occurrence are quite clear, very few clear indications have been reported in those cases of relapse. The authors, after an extensive review of the published literature, aimed to summarize the modalities and the histopathological patterns of HCC recurrence, their prognostic value, and the main surgical strategies to deal with HCC relapse. At this point, either for redo hepatectomy or salvage liver transplantation, the pros and the cons have been detailed with the aim of characterizing the most suitable patients for receiving one or another. Some studies where such treatments were compared have been reported as well. ABSTRACT: Hepatocellular carcinoma (HCC) is the most common primary liver cancer, and both liver resection and liver transplantation are considered potentially curative options. However, high recurrence rates affect the prognosis depending both on the primary HCC pathology characteristics or on the type and time of the relapse. While great attention has been usually posted on treatment algorithms for the first HCC, treatment algorithms for recurrent HCC (rHCC) are lacking. In these cases, surgery still represents a curative option with both redo hepatectomy and/or salvage liver transplantation, which are considered valid treatments in selected patients. In the current era of personalised medicine with promises of new systemic-targeted immuno-chemotherapies, we wished to perform a narrative review of the literature on the role of surgical strategies for rHCC. MDPI 2023-01-13 /pmc/articles/PMC9856445/ /pubmed/36672457 http://dx.doi.org/10.3390/cancers15020508 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Milana, Flavio
Polidoro, Michela Anna
Famularo, Simone
Lleo, Ana
Boldorini, Renzo
Donadon, Matteo
Torzilli, Guido
Surgical Strategies for Recurrent Hepatocellular Carcinoma after Resection: A Review of Current Evidence
title Surgical Strategies for Recurrent Hepatocellular Carcinoma after Resection: A Review of Current Evidence
title_full Surgical Strategies for Recurrent Hepatocellular Carcinoma after Resection: A Review of Current Evidence
title_fullStr Surgical Strategies for Recurrent Hepatocellular Carcinoma after Resection: A Review of Current Evidence
title_full_unstemmed Surgical Strategies for Recurrent Hepatocellular Carcinoma after Resection: A Review of Current Evidence
title_short Surgical Strategies for Recurrent Hepatocellular Carcinoma after Resection: A Review of Current Evidence
title_sort surgical strategies for recurrent hepatocellular carcinoma after resection: a review of current evidence
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856445/
https://www.ncbi.nlm.nih.gov/pubmed/36672457
http://dx.doi.org/10.3390/cancers15020508
work_keys_str_mv AT milanaflavio surgicalstrategiesforrecurrenthepatocellularcarcinomaafterresectionareviewofcurrentevidence
AT polidoromichelaanna surgicalstrategiesforrecurrenthepatocellularcarcinomaafterresectionareviewofcurrentevidence
AT famularosimone surgicalstrategiesforrecurrenthepatocellularcarcinomaafterresectionareviewofcurrentevidence
AT lleoana surgicalstrategiesforrecurrenthepatocellularcarcinomaafterresectionareviewofcurrentevidence
AT boldorinirenzo surgicalstrategiesforrecurrenthepatocellularcarcinomaafterresectionareviewofcurrentevidence
AT donadonmatteo surgicalstrategiesforrecurrenthepatocellularcarcinomaafterresectionareviewofcurrentevidence
AT torzilliguido surgicalstrategiesforrecurrenthepatocellularcarcinomaafterresectionareviewofcurrentevidence